Primary dysmenorrhea: current concepts

American family physician · 1981 · vol. 24(5) , pp. 129–34 · PMID:7197460 · W2433528642
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This review defines primary dysmenorrhea as non-pathological menstrual pain linked to increased myometrial activity, noting that effective treatment with oral contraceptives or prostaglandin inhibitors requires excluding secondary causes like endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Primary dysmenorrhea is menstrual pain that is not associated with pelvis pathology. It usually begins with the onset of ovulatory cycles, characteristically appearing in the year after menarche and increasing with time. The pain is associated with increased myometrial activity. Oral contraceptives and prostaglandin synthetase inhibitors are effective in alleviating symptoms. Causes of secondary dysmenorrhea, such as pelvic inflammatory disease, endometriosis and uterine myomas, must be excluded before treatment is given.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosis

MeSH descriptors

Dysmenorrhea Adolescent Adolescent Adult Adult Contraceptives, Oral, Combined Contraceptives, Oral, Combined Contraceptives, Oral, Combined Diagnosis, Differential Diagnosis, Differential Dysmenorrhea Dysmenorrhea Dysmenorrhea Dysmenorrhea Female Female Humans Humans Premenstrual Syndrome Premenstrual Syndrome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:58:37.372514+00:00
License: CC0 · commercial use OK